These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19396119)

  • 1. Stem cells: Fast and furious.
    Baker M
    Nature; 2009 Apr; 458(7241):962-5. PubMed ID: 19396119
    [No Abstract]   [Full Text] [Related]  

  • 2. Derivation of novel naive-like porcine embryonic stem cells by a reprogramming factor-assisted strategy.
    Zhang M; Wang C; Jiang H; Liu M; Yang N; Zhao L; Hou D; Jin Y; Chen Q; Chen Y; Wang J; Dai Y; Li R
    FASEB J; 2019 Aug; 33(8):9350-9361. PubMed ID: 31125263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Export and expression: mRNAs deliver new messages for controlling pluripotency.
    Saunders A; Wang J
    Cell Stem Cell; 2014 May; 14(5):549-50. PubMed ID: 24792108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
    Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
    Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming human cells to naïve pluripotency: how close are we?
    Bates LE; Silva JC
    Curr Opin Genet Dev; 2017 Oct; 46():58-65. PubMed ID: 28668635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground rules of the pluripotency gene regulatory network.
    Li M; Belmonte JC
    Nat Rev Genet; 2017 Mar; 18(3):180-191. PubMed ID: 28045100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of human embryonic stem cell technologies to drug discovery.
    Sartipy P; Björquist P; Strehl R; Hyllner J
    Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Human Naïve Pluripotent Stem Cells - Evaluating State-Specific Reporter Lines and Cell-Surface Markers.
    Collier AJ; Rugg-Gunn PJ
    Bioessays; 2018 May; 40(5):e1700239. PubMed ID: 29574793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells: Tailor-made diseased neurons.
    Sendtner M
    Nature; 2009 Jan; 457(7227):269-70. PubMed ID: 19148087
    [No Abstract]   [Full Text] [Related]  

  • 10. End of inevitability: programming and reprogramming.
    Turksen K
    Stem Cell Rev Rep; 2013 Aug; 9(4):385-7. PubMed ID: 23892888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells: what lies beyond the paradigm shift.
    Cox JL; Rizzino A
    Exp Biol Med (Maywood); 2010 Feb; 235(2):148-58. PubMed ID: 20404029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the human naïve pluripotent state.
    Manor YS; Massarwa R; Hanna JH
    Curr Opin Genet Dev; 2015 Oct; 34():35-45. PubMed ID: 26291026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy to Establish Embryo-Derived Pluripotent Stem Cells in Cattle.
    Kim D; Roh S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms underlying differentiation of primordial germ cells and their reprogramming to pluripotential stem cells].
    Matsui Y
    Seikagaku; 2014 Dec; 86(6):726-34. PubMed ID: 25675810
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of epiblast stem cells to embryonic stem cells using growth factors and small molecule inhibitors.
    Rao J; Greber B
    Methods Mol Biol; 2014; 1150():215-26. PubMed ID: 24744001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.
    Jang H; Kim TW; Yoon S; Choi SY; Kang TW; Kim SY; Kwon YW; Cho EJ; Youn HD
    Cell Stem Cell; 2012 Jul; 11(1):62-74. PubMed ID: 22608532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
    Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine embryonic stem cell derivation, in vitro pluripotency characterization, and in vivo teratoma formation.
    Chou YF; Yabuuchi A
    Curr Protoc Toxicol; 2011 Nov; Chapter 2():Unit2.22. PubMed ID: 22058054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of gene regulation in human embryos and pluripotent stem cells.
    Theunissen TW; Jaenisch R
    Development; 2017 Dec; 144(24):4496-4509. PubMed ID: 29254992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in iPS cell research do not obviate the need for human embryonic stem cells.
    Hyun I; Hochedlinger K; Jaenisch R; Yamanaka S
    Cell Stem Cell; 2007 Oct; 1(4):367-8. PubMed ID: 18371375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.